impact of recent data on guidelines for management of her2-positive breast cancer
Published 9 years ago • 516 plays • Length 32:19Download video MP4
Download video MP3
Similar videos
-
22:50
neoadjuvant therapy for her2-positive breast cancer - dr. scott christensen
-
46:51
her2 in breast cancer: testing guidelines and new treatment approaches
-
20:13
advanced hormone receptor-positive breast cancer
-
0:35
key challenge associated with the management of hr /her2- breast cancer
-
54:02
navigating shifts in the treatment landscape for metastatic her2-positive breast cancer
-
59:05
updates in the management of her2 positive breast cancer
-
53:19
her2 positive breast cancer: what's new in treatment and research at mbc patient forum 2019
-
16:53
breast cancer breakthroughs episode 5: moving the needle for her2-positive breast cancer
-
2:43
margetuximab for the treatment of her2-positive breast cancer
-
22:48
adjuvant therapy of breast cancer
-
1:03:59
selecting and sequencing of her2-targeting therapies in her2-positive metastatic breast cancer
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
25:20
her2 low breast cancer a new therapeutic subtype | 2023 ku breast cancer year in review conference
-
6:08
first-line treatment of her2-positive metastatic breast cancer
-
1:48
dr. verma on advances in the treatment of metastatic her2-positive breast cancer
-
8:40
first-line treatment of her2-positive metastatic breast cancer
-
1:31
current treatment options for patients with her2-positive metastatic breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases